From Clinical Infect Diseases Journal:
A number of events conspired to diminish public support for a Lyme disease vaccine, and this, in combination with class action lawsuits, led the manufacturer to decide to voluntarily withdraw the product from the market, citing insufficient sales volume.
Post Edited (BarnGurl) : 3/30/2014 6:44:18 AM (GMT-6)